Stay updated on Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no changes to the study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-03T23:44:04.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows a glossary and the 'Last Update Submitted that Met QC Criteria' entry, and includes 'No FEAR Act Data' along with the revision note 'v3.4.0' (replacing 'v3.3.4').
    Difference
    0.2%
    Check dated 2026-01-28T00:39:29.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A minor revision update from v3.3.3 to v3.3.4 appears in the page's record history; no changes to study content or eligibility criteria are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:46:58.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Maryland listed as a site, and updated the revision tag; the previous Maryland Locations entry and older revision tag were removed.
    Difference
    0.2%
    Check dated 2025-12-23T17:29:33.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision label on the page was updated from v3.2.0 to v3.3.2; no substantive changes to the study details or navigation were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T20:57:30.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    A general operating-status funding notice was removed; there are no changes to the study details, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T18:18:01.000Z thumbnail image

Stay in the know with updates to Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Tadalafil, Vancomycin in Liver Cancer Clinical Trial page.